...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Europe

I doubt we get a webcast, but hopefully the slide deck from tomorrow's Zenith BIO-Europe presentation will be posted. 

Zenith presents Tuesday November 6 at 9:30 AM Copenhagen time.  

Share
New Message
Please login to post a reply